2102-LB: Dysregulation of Cholesterol Homeostasis Is an Early Signal of Beta-Cell Proteotoxicity Characteristic of Type 2 Diabetes

Tatyana Gurlo(University of California, Los Angeles), Peter C. Butler(University of California, Los Angeles), XIA YANG, Montgomery Blencowe(University of California, Los Angeles), Ruoshui Liu(University of California, Los Angeles)
Diabetes
June 14, 2024
10.2337/db24-2102-lb
Cited by 0

Related Papers

Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
|Diabetes|2013|455
Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model
|Diabetes|2012|247
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes
|Diabetologia|2006|180
β-Cell Dysfunctional ERAD/Ubiquitin/Proteasome System in Type 2 Diabetes Mediated by Islet Amyloid Polypeptide–Induced UCH-L1 Deficiency
|Diabetes|2010|122
Activation of Peroxisome Proliferator-Activated Receptor-γ by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3′-Kinase-Dependent Pathway
|The Journal of Clinical Endocrinology & Metabolism|2005|103